ClinicalTrials.gg
RecruitingNCT07184411ENGAGE-CPUpdated Aug 24, 2026

Activities-based Locomotor Training in Children With Cerebral Palsy

An interventional study of Activities-based locomotor training and physical therapy in Cerebral Palsy (CP), sponsored by Baylor University. Recruiting at 1 site in United States. Open to participants aged 2 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Baylor University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
2 Years to 6 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Planned enrollment
179th of 296
19 · median 25
Started
2026
with 23 others
No phase
218 of 372
49 open now
Primary completion
2028-05
later than 67 of 101 live
Registered
347th of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 179th largest by planned enrollment of the 296 interventional ones that give a count, is one of 24 that started in 2026, is one of 218 with no phase, reaches primary completion later than 67 of the 101 other live ones, and was the 347th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

68 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 2 Years to 6 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

This project aims to improve the quality of life and functional outcomes for young non-ambulatory children with Cerebral Palsy (CP) by investigating the efficacy of an Activities-Based Locomotor Training (AB-LT) program compared to usual care. By targeting the body structures, activities, and participation components of the World Health Organization's International Classification of Functioning, Disability, and Health (ICF) framework, this study seeks to enhance our understanding of neuroplasticity and motor learning in this population, offering a novel approach to rehabilitation. Results from this research will lead to more effective, individualized therapies that improve motor function, reduce disability, and ultimately lower the long-term healthcare needs associated with CP.

03

Conditions studied

  • Cerebral Palsy (CP)

Browse trials for

Keywords

  • Cerebral Palsy
  • Locomotor Training
  • Physical Therapy
04

Who can participate

Ages eligible
2 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: To be eligible for this study, the child must be:

    • Able to hold their head upright for 5 seconds when supported at the trunk in sitting (the minimal amount of head control necessary for safe walking on the partial body weight support system during the AB-LT intervention);

      • Non-ambulatory or not walking as primary means of mobility;
      • Willing to attend the AB-LT intervention at Fortis Therapy Center in Dripping Springs, Texas for 3 hours/ day, 5 days/week, for 3 weeks; and
      • Willing to commit to a total of 7 weeks of the study, and to continue their usual care during the time period in which they are not enrolled in the AB-LT intervention.

Exclusion Criteria: The child must not have:

    • Surgery or botulinum toxin injections in the previous 6 months;

      • Uncontrolled epilepsy; and
      • Uncontrolled cardiovascular disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
19 participants (estimated)

Study arms

  • Experimental
    Activities-based locomotor training (AB-LT)

    Child will participate in a 3-week intensive AB-LT training program. The child will attend the AB-LT session for a total of 3 hours, 5 days a week for 3 weeks. The AB-LT session will consist of 1 hour of walking and standing in a harness on a treadmill, followed by an hour of play-based physical therapy, then followed by a final 1 hour of walking and standing in a harness on a treadmill. All sessions will be run by a licensed physical therapist who is trained in AB-LT.

    Other: Activities-based locomotor training

  • Active comparator
    Usual care

    During this arm, the child will resume or continue their usual therapy schedule, which may include physical therapy, occupational therapy, and/or speech language pathology. No restrictions will be placed on the type or amount of therapy in which the child can participate.

    Other: physical therapy

Interventions

  • OtherActivities-based locomotor training

    Activities-based locomotor training involves placing the child in a partial body-weight supported (PBWS) system over a treadmill. The child is given assistance by trained clinicians to attempt standing and walking on the treadmill for 1 hour. The child then participates in play-based activities aimed to foster independence in an overground (regular) environment for 1 hour. The final hour of the 3-hour session is conducted in the PBWS system with a focus on standing and walking.

  • Otherphysical therapy

    In this intervention, the child will attend their usual physical therapy sessions.

06

What researchers measure

Primary outcomes

  1. Gross Motor Function Measure (GMFM-66)

    The GMFM-66 is the gold standard for measuring gross motor function in children with CP. A child's capabilities are scored across five dimensions (66 items), including Lying and Rolling (Dimension A), Sitting (Dimension B), Crawling and Kneeling (Dimension C), Standing (Dimension D), and Walking, Running, and Jumping (Dimension E).

    Time frame: 4 testing sessions: Baseline, end of week 3, end of week 4, end of week 7.

Secondary outcomes

  1. functional near infrared spectroscopy (fNIRS)

    functional near-infrared spectroscopy (fNIRS) is a non-invasive neuroimaging technique that uses infrared light to assess hemodynamic shifts in the prefrontal cortex during movement. It involves wearing a lightweight neoprene headband that contains sensors.

    Time frame: 4 testing sessions: Baseline, end of week 3, end of week 4, end of week 7.

  2. Child Engagement in Daily Life (CEDL)

    The Child Engagement in Daily Life (CEDL) is a survey completed by parents or caregivers of children, 18 months through 12 years of age. The CEDL describes a child's participation in daily activities such as interactions with others, play, and self-care.

    Time frame: 4 testing sessions: Baseline, end of week 3, end of week 4, end of week 7.

07

Study locations

1 of 1 sites recruiting
  • Fortis Therapy Center
    Dripping Springs, Texas 78620, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified raw data includes child functional near infrared spectroscopy (fNIRS), child functional gross motor ability levels obtained from the Gross Motor Function Measure (GMFM-66), Child Engagement in Daily Life survey data collected from primary caregivers, and parent-reported demographic information. Analyzed data that will be shared at the conclusion of the project includes statistical models, and descriptive analysis.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: Data will be made available at the time of associated publication or by the end of the project, whichever comes first. Data will be available in REDCap for at least 10 years.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for May 2028, 27 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 27 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2025
First posted
Sep 19, 2025
StartActual
Jan 11, 2026
Primary completionEst.
May 1, 2028
CompletionEst.
Aug 31, 2028
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07184411
Lead sponsor
Baylor University
Responsible party
Sponsor
First posted
Sep 19, 2025
Start date
Jan 11, 2026
Primary completion
May 1, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Aug 24, 2026

Study contacts

Elizabeth Ardolino, PhD, PT
Contact
liz_ardolino@baylor.edu
215-605-9319
Megan Flores, PhD, PT
Contact
megan_flores@baylor.edu
Elizabeth Ardolino, PhD, PT
principal investigator · Baylor University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion